University of California San Francisco
Give to UCSF
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.
No one can see the future, but that won’t stop us from trying. We asked UCSF faculty and alumni to score these predictions for likelihood and impact.
Adam L. Boxer answers questions about the potential of "basket trials" to accelerate drug development for dementia and neurodegenerative disease.
The net clinical benefit of anticoagulants for atrial fibrillation decreases with age.
The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and UC San Francisco, to advance treatments for frontotemporal lobar degeneration.
Scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia, adding to growing evidence that the loss of brain cells associated with dementia spreads via the synaptic connections between established brain networks.
